×
Pour une meilleure utilisation, nous vous conseillons d’activer Javascript dans votre navigateur.
VEGFR2/CD309 anticorps (PerCP-Cy5.5)
VEGFR2
Reactivité: Souris
WB, IHC, ICFC
Hôte: Rat
Monoclonal
Avas12
PerCP-Cy5.5
N° du produit ABIN2660083
Détail du produit anti-VEGFR2/CD309 anticorps (PerCP-Cy5.5)
(cache)
Antigène
Voir toutes VEGFR2/CD309 (VEGFR2) Anticorps
VEGFR2/CD309 (VEGFR2)
(VEGF Receptor 2 (VEGFR2))
Reactivité
Toutes les réactivités sur VEGFR2/CD309 Anticorps
Souris
Hôte
Toutes les hôtes sur VEGFR2/CD309 Anticorps
Rat
Clonalité
Toutes les clonalités sur VEGFR2/CD309 Anticorps
Monoclonal
Conjugué
Tous les conjugués à travers VEGFR2/CD309 Anticorps
Cet anticorp VEGFR2/CD309 est conjugé à/à la PerCP-Cy5.5
Application
Tous les applications à travers VEGFR2/CD309 Anticorps.
Western Blotting (WB), Immunohistochemistry (IHC), Intracellular Flow Cytometry (ICFC)
Purification
The antibody was purified by affinity chromatography and conjugated with PerCP/Cy5.5 under optimal conditions. The solution is free of unconjugated PerCP/Cy5.5 and unconjugated antibody.
Clone
Avas12
Isotype
IgG2a kappa
Top Product
Discover our top product VEGFR2 Anticorps primaire
Alternatives
(show)
Information d'application
(cache)
Indications d'application
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Stockage
(cache)
Concentration
0.2 mg/mL
Buffer
Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide.
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Conseil sur la manipulation
Protect from prolonged exposure to light. Do not freeze.
Stock
4 °C
Stockage commentaire
The antibody solution should be stored undiluted between 2°C and 8°C.
Détails sur VEGFR2/CD309
(cache)
Antigène
VEGFR2/CD309 (VEGFR2)
(VEGF Receptor 2 (VEGFR2))
Autre désignation
CD309 (VEGFR2 Produits )
Synonymes
anticorps CD309, anticorps FLK1, anticorps VEGFR, anticorps VEGFR2, anticorps 6130401C07, anticorps Flk-1, anticorps Flk1, anticorps Krd-1, anticorps Ly73, anticorps VEGFR-2, anticorps sVEGFR-2, anticorps Vegfr-2, anticorps FLK-1, anticorps flk-1, anticorps vegfr-2, anticorps KDR, anticorps FLK/KDR, anticorps flk1, anticorps flk1b, anticorps kdrb, anticorps si:busm1-205d10.1, anticorps si:ch211-254j6.1, anticorps si:ch211-278f21.4, anticorps wu:fc31a09, anticorps fk52c05, anticorps flk, anticorps kdr, anticorps kdra, anticorps vegfr2, anticorps vegfr4, anticorps vegr2, anticorps wu:fk52c05, anticorps kinase insert domain receptor, anticorps kinase insert domain protein receptor, anticorps vascular endothelial growth factor receptor kdr-like, anticorps kinase insert domain receptor (a type III receptor tyrosine kinase), anticorps kinase insert domain receptor like, anticorps KDR, anticorps Kdr, anticorps LOC100136647, anticorps kdr, anticorps kdrl
Sujet
CD309 is also known as vascular endothelial growth factor receptor 2 (VEGFR2) and fetal liver kinase-1 (Flk-1). CD309 is a member of the tyrosine protein kinase family that contains a single pass transmembrane receptor with a protein kinase domain and seven immunoglobulin-like domains in the extracellular region. CD309 is expressed at high levels in adult heart, lung, kidney, brain, and skeletal muscle. It's a receptor for VEGF or VEGFC, and plays an important role in the development of vascular endothelial cells, hematopoietic cells, and vascular permeability.
Pathways
Signalisation RTK , Glycosaminoglycan Metabolic Process , Signaling Events mediated by VEGFR1 and VEGFR2 , Growth Factor Binding , Regulation of long-term Neuronal Synaptic Plasticity , VEGF Signaling
Vus récemment
(cache)